Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
In the Basic model, a significant effect of vitamin D supplementation was observed only for DISYPS Proxy (Table 2).
Source: Effect modification by baseline CRP levels. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Secondary analysis.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Meta-analysis unclear · Double-blind reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
All participants were deficient in vitamin D [25(OH)D ≤ 30 nmol/l] and at least mild depressive symptoms [Beck Depression Inventory-II (BDI-II) ≥ 14].
Source: Abstract.
This secondary analysis is based on a randomized, double-blind, placebo-controlled trial conducted at the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, Germany (LVR-Universitätsklinik Essen), between June 2016 and May 2018 [].
Source: Methods.
This secondary analysis is based on a randomized, double-blind, placebo-controlled trial conducted at the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, Germany (LVR-Universitätsklinik Essen), between June 2016 and May 2018 [].
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Does inflammation moderate the effect of vitamin D supplementation on depressive symptoms? Results of an interventional study in children and adolescents
Secondary analysis · European Journal of Nutrition · 2026
Original publication title
Does inflammation moderate the effect of vitamin D supplementation on depressive symptoms? Results of an interventional study in children and adolescents
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Studies in adults suggest antidepressant effects of vitamin D, possibly via anti-inflammatory pathways, but evidence in youth is lacking. In the first randomized controlled trial (RCT) in depressed, vitamin D-deficient adolescents (DRKS00009758), symptom reduction emerged in only one of three outcomes. This secondary analysis investigates whether baseline inflammatory status modifies the effect of vitamin D.
Source: PurposeAbstract: What methods does the paper describe?
Data from 92 participants (78.3% ♀) of the RCT conducted at the Department of Child and Adolescent Psychiatry were analyzed. All participants were deficient in vitamin D [25(OH)D ≤ 30 nmol/l] and at least mild depressive symptoms [Beck Depression Inventory-II (BDI-II) ≥ 14]. Participants received 2640 IU/day of vitamin D or placebo for 28 days plus treatment as usual. Depressive symptoms were assessed via BDI-II and the Diagnostic System for Mental Disorders in Childhood and Adolescence (DISYPS), self: and proxy-rated.
C-reactive protein (CRP) was measured at baseline as an inflammatory marker. Its impact on treatment effects was examined via interaction analyses and stratification by CRP status.
Source: MethodsAbstract: Results
In 81.5% of the participants, CRP levels were below the threshold for low-grade inflammation (3 mg/L). No consistent interaction between treatment and baseline CRP was observed across outcomes. A nominal interaction for self-rated DISYPS at the 3 mg/L threshold lost significance after correction for multiple testing. Stratified analyses using different CRP thresholds revealed no significant subgroup effects.
Source: ResultsAbstract: Conclusions
Overall, our findings do not support the hypothesis that the antidepressant effects of vitamin D supplementation in children and adolescents depend on baseline CRP status: at least within a sample characterized by minimal baseline inflammation.
Source: ConclusionsAuthors’ abstract
Purpose
Studies in adults suggest antidepressant effects of vitamin D, possibly via anti-inflammatory pathways, but evidence in youth is lacking. In the first randomized controlled trial (RCT) in depressed, vitamin D-deficient adolescents (DRKS00009758), symptom reduction emerged in only one of three outcomes. This secondary analysis investigates whether baseline inflammatory status modifies the effect of vitamin D.
Methods
Data from 92 participants (78.3% ♀) of the RCT conducted at the Department of Child and Adolescent Psychiatry were analyzed. All participants were deficient in vitamin D [25(OH)D ≤ 30 nmol/l] and at least mild depressive symptoms [Beck Depression Inventory-II (BDI-II) ≥ 14]. Participants received 2640 IU/day of vitamin D or placebo for 28 days plus treatment as usual. Depressive symptoms were assessed via BDI-II and the Diagnostic System for Mental Disorders in Childhood and Adolescence (DISYPS), self: and proxy-rated.
C-reactive protein (CRP) was measured at baseline as an inflammatory marker. Its impact on treatment effects was examined via interaction analyses and stratification by CRP status.
Results
In 81.5% of the participants, CRP levels were below the threshold for low-grade inflammation (3 mg/L). No consistent interaction between treatment and baseline CRP was observed across outcomes. A nominal interaction for self-rated DISYPS at the 3 mg/L threshold lost significance after correction for multiple testing. Stratified analyses using different CRP thresholds revealed no significant subgroup effects.
Conclusions
Overall, our findings do not support the hypothesis that the antidepressant effects of vitamin D supplementation in children and adolescents depend on baseline CRP status: at least within a sample characterized by minimal baseline inflammation.
Publication and source details
Original title: Does inflammation moderate the effect of vitamin D supplementation on depressive symptoms? Results of an interventional study in children and adolescents
Laura Schlarbaum; Nicole Jankovic; Judith Bühlmeier; Eva Hohoff; Rhea Dankers; Harald Engler; Raphael Hirtz; Denise Zwanziger; Corinna Grasemann; Triinu Peters; Anke Hinney; Jochen Antel; Manuel Föcker; Lars Libuda
European Journal of Nutrition · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Universität Paderborn (3159)Open Access funding enabled and organized by Projekt DEAL.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T16:30:57.023952+00:00
DOI: 10.1007/s00394-026-03920-0 · PMC13038648